A compound with the SMILES CC(C)(C)OC(=O)NCCCC[C@H](NC(=O)OC(C)(C)C)c1nnc([C@H](Cc2ccc(OC(C)(C)C)cc2)NC(=O)C2CCN(C(=O)OC(C)(C)C)CC2)o1 has a hERG inhibition at a concentration of 1uM of -3.833\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CC(C)(C)OC(=O)NCCCC[C@H](NC(=O)OC(C)(C)C)c1nnc([C@H](Cc2ccc(OC(C)(C)C)cc2)NC(=O)C2CCN(C(=O)OC(C)(C)C)CC2)o1
CC(C)(C)OC(=O)NCCCC[C@H](NC(=O)OC(C)(C)C)c1nnc([C@H](Cc2ccc(OC(C)(C)C)cc2)NC(=O)C2CCN(C(=O)OC(C)(C)C)CC2)o1
tert-butyl 4-[[(1S)-1-[5-[(1S)-1,5-bis[(2-methylpropan-2-yl)oxycarbonylamino]pentyl]-1,3,4-oxadiazol-2-yl]-2-[4-[(2-methylpropan-2-yl)oxy]phenyl]ethyl]carbamoyl]piperidine-1-carboxylate